Vissing John, Quistorff Bjørn, Haller Ronald G
Copenhagen Muscle Research Center, National University Hospital, Denmark.
Arch Neurol. 2005 Sep;62(9):1440-3. doi: 10.1001/archneur.62.9.1440.
Muscle phosphoglycerate mutase deficiency (PGAMD) is a rare, recessively inherited metabolic myopathy that affects one of the last steps of glycolysis. Clinically, PGAMD resembles muscle phosphorylase deficiency (McArdle disease) and phosphofructokinase deficiency (PFKD). However, it is unknown whether PGAMD is associated with a second-wind phenomenon during exercise, as in McArdle disease, and whether patients with PGAMD, like patients with PFKD and McArdle disease, benefit from supplementation with fuels that bypass the metabolic block.
To investigate whether fuels that bypass the metabolic block can improve exercise capacity or whether exercise capacity improves during sustained exercise.
Single-blind, placebo-controlled investigation of the effects of glucose, lactate, and intralipid on work capacity in patients with PGAMD.
National University Hospital, University of Copenhagen, and Neuromuscular Center, Institute for Exercise and Environmental Medicine. Patients Two unrelated men (21 and 26 years old) with PGAMD who since their teens had experienced muscle cramps, muscle pain, and episodes of myoglobinuria provoked by brief vigorous exercise, 4 patients with McArdle disease (mean +/- SD age, 32 +/- 5 years) with 0% residual phosphorylase activity in muscle, and 6 healthy, untrained male volunteers (mean +/- SD age, 23 +/- 1 years) were studied.
Using constant and variable workload protocols on a cycle ergometer, it was investigated whether a spontaneous second wind occurs during exercise in patients with PGAMD, and using a constant workload protocol followed by an incremental load to exhaustion, it was tested whether infusion of lactate, glucose, or intralipid alters the exercise tolerance in PGAMD.
Whether a second wind occurs during exercise and whether fuels that bypass the metabolic block can improve exercise and oxidative capacity.
In contrast to patients with McArdle disease, with whom they share many clinical features, in patients with PGAMD, cycle exercise and oxidative capacity are virtually normal, a second wind does not occur, and lipid and lactate supplements do not improve exercise capacity.
Although the clinical manifestations of PGAMD mimic McArdle disease with respect to the presence of exertional muscle cramps, rhabdomyolysis, and myoglobinuria, this study shows that cycle exercise responses are strikingly different.
肌肉磷酸甘油酸变位酶缺乏症(PGAMD)是一种罕见的隐性遗传代谢性肌病,影响糖酵解的最后步骤之一。临床上,PGAMD类似于肌肉磷酸化酶缺乏症(麦克尔迪氏病)和磷酸果糖激酶缺乏症(PFKD)。然而,尚不清楚PGAMD是否像麦克尔迪氏病那样在运动期间与第二次呼吸现象有关,以及PGAMD患者是否像PFKD和麦克尔迪氏病患者一样能从补充绕过代谢障碍的燃料中获益。
研究绕过代谢障碍的燃料是否能提高运动能力,或者持续运动期间运动能力是否会提高。
对葡萄糖、乳酸和脂肪乳对PGAMD患者工作能力影响的单盲、安慰剂对照研究。
哥本哈根大学国立大学医院以及运动与环境医学研究所神经肌肉中心。患者:两名患有PGAMD的无血缘关系男性(分别为21岁和26岁),自青少年时期起就经历过因短暂剧烈运动引发的肌肉痉挛、肌肉疼痛和肌红蛋白尿发作;4名麦克尔迪氏病患者(平均年龄±标准差为32±5岁),肌肉中磷酸化酶活性残余为0%;以及6名健康的未经训练的男性志愿者(平均年龄±标准差为23±1岁)参与了研究。
在自行车测力计上采用恒定和可变工作量方案,研究PGAMD患者运动期间是否会出现自发的第二次呼吸现象;采用恒定工作量方案,随后进行递增负荷直至疲劳,测试输注乳酸、葡萄糖或脂肪乳是否会改变PGAMD患者的运动耐力。
运动期间是否出现第二次呼吸现象,以及绕过代谢障碍的燃料是否能提高运动和氧化能力。
与具有许多临床特征相同的麦克尔迪氏病患者不同,PGAMD患者的循环运动和氧化能力基本正常,不会出现第二次呼吸现象,脂质和乳酸补充剂也不会提高运动能力。
尽管PGAMD在运动性肌肉痉挛、横纹肌溶解和肌红蛋白尿方面的临床表现与麦克尔迪氏病相似,但本研究表明循环运动反应截然不同。